SEARCH

SEARCH BY CITATION

References

  • 1
    Kreis HA, Ponticelli C. Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors. Transplantation 2001; 71 (11 Suppl): SS5SS9.
  • 2
    Joosten SA, Sijpkens YW, Van Kooten C, Paul LC. Chronic renal allograft rejection: Pathophysiologic considerations. Kidney Int 2005; 68: 113.
  • 3
    Blobel CP. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNF alpha and Notch. Cell 1997; 90: 589592.
  • 4
    Stone AL, Kroeger M, Sang QX. Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review). J Protein Chem 1999; 18: 447465.
  • 5
    Wolfsberg TG, Primakoff P, Myles DG, White JM. ADAM, a novel family of membrane proteins containing A Disintegrin and Metalloprotease domain: Multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 1995; 131: 275278.
  • 6
    Blobel CP. Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol 2000; 12: 606612.
  • 7
    Primakoff P, Myles DG. The ADAM gene family: Surface proteins with adhesion and protease activity. Trends Genet 2000; 16: 8387.
  • 8
    Fritsche J, Moser M, Faust S et al. Molecular cloning and characterization of a human metalloprotease disintegrin–a novel marker for dendritic cell differentiation. Blood 2000; 96: 732739.
  • 9
    Wei P, Zhao YG, Zhuang L, Ruben S, Sang QX. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta. Biochem Biophys Res Commun 2001; 280: 744755.
  • 10
    Chesneau V, Becherer JD, Zheng Y, Erdjument-Bromage H, Tempst P, Blobel CP. Catalytic properties of ADAM19. J Biol Chem 2003; 278: 2233122340.
  • 11
    Fata JE, Kong YY, Li J et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000; 103: 4150.
  • 12
    Kong YY, Yoshida H, Sarosi I et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397: 315323.
  • 13
    Lacey DL, Timms E, Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165176.
  • 14
    Zheng Y, Saftig P, Hartmann D, Blobel C. Evaluation of the contribution of different ADAMs to TNFa shedding and of the function of the TNFa ectodomain in ensuring selective stimulated shedding by the TNFa convertase (TACE/ADAM17). J Biol Chem, 2004; 279: 4289842906.
  • 15
    Lautrette A, Li S, Alili R et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat Med 2005; 11: 867874.
  • 16
    Roemer A, Schwettmann L, Jung M et al. The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers? J Urol 2004; 172: 21622166.
  • 17
    Roemer A, Schwettmann L, Jung M et al. Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome. Oncol Rep 2004; 11: 529536.
  • 18
    Shirakabe K, Wakatsuki S, Kurisaki T, Fujisawa-Sehara A. Roles of Meltrin beta/ADAM19 in the processing of neuregulin. J Biol Chem 2001; 276: 93529358.
  • 19
    Horiuchi K, Zhou HM, Kelly K, Manova K, Blobel CP. Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev Biol 2005; 283: 459471.
  • 20
    Zhou HM, Weskamp G, Chesneau V et al. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol 2004; 24: 96104.
  • 21
    Kurohara K, Komatsu K, Kurisaki T et al. Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol 2004; 267: 1428.
  • 22
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 23
    Van Den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 1999; 154: 16851691.
  • 24
    Van Der Leij J, Van Den Berg A, Albrecht EW et al. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells. Transplantation 2003; 75: 20762082.
  • 25
    Inkinen KA, Soots AP, Krogerus LA, Lautenschlager IT, Ahonen JP. Fibrosis and matrix metalloproteinases in rat renal allografts. Transpl Int 2005; 18: 506512.
  • 26
    Gould RJ, Polokoff MA, Friedman PA et al. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 1990; 195: 168171.
  • 27
    Zhang XP, Kamata T, Yokoyama K, Puzon-McLaughlin W, Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J Biol Chem 1998; 273: 73457350.
  • 28
    Eto K, Puzon-McLaughlin W, Sheppard D, Sehara-Fujisawa A, Zhang XP, Takada Y. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J Biol Chem 2000; 275: 3492234930.
  • 29
    Mishra R, Leahy P, Simonson MS. Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol 2002; 283: F1151F1159.
  • 30
    Terzi F, Burtin M, Hekmati M et al. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest 2000; 106: 225234.
  • 31
    Hernandez-Fuentes MP, Baker RJ, Lechler RI. The alloresponse. Rev Immunogenet 1999; 1: 282296.
  • 32
    Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 1996; 60: 540545.
  • 33
    Perri RT, Kay NE, McCarthy J, Vessella RL, Jacob HS, Furcht LT. Fibronectin enhances in vitro monocyte-macrophage-mediated tumoricidal activity. Blood 1982; 60: 430435.